Related Experiment Video
Updated: Jun 15, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
A potential therapeutic for pandemic influenza using RNA interference
Shaguna Seth1, Michael V Templin, Gregory Severson
1Department of Pharmacology, Toxicology and Virology, MDRNA Inc., Bothell, WA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2010
Summary
This study details methods for selecting effective small interfering RNAs (siRNAs) to combat influenza virus. These findings could advance RNA interference (RNAi) therapeutics for respiratory infections.
Area of Science:
- Biotechnology
- Virology
- Molecular Biology
Background:
- RNA interference (RNAi) utilizes sequence-specific gene silencing via small interfering RNAs (siRNAs).
- siRNA therapeutics show promise for antiviral applications, particularly against respiratory viruses like influenza.
- Current challenges in siRNA therapy include effective delivery and achieving complete protection against diverse influenza strains.
Purpose of the Study:
- To describe methods for screening and selecting potent influenza-specific siRNAs.
- To evaluate the efficacy of selected siRNAs in cell culture, mouse, and ferret models.
- To assess the potential of RNAi as a therapeutic strategy for influenza.
Main Methods:
- Screening and selection of influenza-specific siRNAs based on sequence targeting conserved viral regions.
- In vitro validation of siRNA efficacy in cell culture models.
- In vivo assessment of siRNA delivery and antiviral activity in mouse and ferret models.
Main Results:
- Identification of highly effective influenza-specific siRNAs through rigorous screening.
- Demonstration of potent inhibition of influenza viral RNA replication in cellular and animal models.
- Evaluation of delivery strategies and their impact on therapeutic outcomes.
Conclusions:
- Established methods for selecting effective influenza-targeting siRNAs.
- RNAi therapeutics show significant potential for controlling influenza virus infections.
- Further evaluation is warranted for clinical application of siRNA-based influenza therapies.
More Related Videos
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...